Teclistamab interference with anti-BCMA chimeric antigen receptor T-cell detection by flow cytometry: duration and clinical implications - PubMed
6 hours ago
- #Teclistamab
- #Flow Cytometry
- #CAR-T Therapy
- Teclistamab interferes with the detection of anti-BCMA CAR-T cells via flow cytometry.
- The study examines the duration of this interference and its clinical implications.
- Research involved ethical approval and patient consent under institutional guidelines.
- Funding and grants were disclosed, including sources from German federal ministries and a university.
- Authors declared competing interests, with some receiving unrelated honoraria from pharmaceutical companies.